Advertisement

Potassium Chloride Injection

[29 November 2016]

Products Affected - Description

Potassium Chloride
Potassium chloride injection, Hospira
2 mEq/mL, 15 mL vial, 25 count (NDC 00409-6636-01) - discontinued
2 mEq/mL, 250 mL bulk package 1 count (NDC 00409-1513-02)
 
Potassium Chloride in Dextrose and Sodium Chloride
Potassium chloride injection, Hospira
10 mEq/500 mL, 5% dextrose and 0.225% sodium chloride 24 count (NDC 00409-7901-03)

Reason for the Shortage

  • Baxter has a consistent supply of potassium chloride injection.
  • Fresenius Kabi has some potassium chloride injection available.
  • Hospira has potassium chloride injection on shortage due to increase demand and manufacturing delays.

Available Products

Potassium Chloride
Potassium chloride injection, BBraun
2 mEq/mL, 250 mL bulk package 1 count (NDC 00264-1940-20)

Potassium chloride injection, Fresenius Kabi
2 mEq/mL, 5 mL vial, 25 count (NDC 63323-0965-05)
2 mEq/mL, 10 mL vial, 25 count (NDC 63323-0965-10)
2 mEq/mL, 20 mL vial, 25 count (NDC 63323-0965-20)
2 mEq/mL, 30 mL vial, 25 count (NDC 63323-0967-30)

Potassium chloride injection, Hospira
2 mEq/mL, 5 mL vial, 25 count (NDC 00409-6635-01)
2 mEq/mL, 10 mL vial, 25 count (NDC 00409-6651-06)
2 mEq/mL, 20 mL vial, 25 count (NDC 00409-6653-05)

Potassium Chloride in Dextrose
Potassium chloride injection, Baxter
20 mEq/L, 5% dextrose 14 count (NDC 00338-0683-04)
 
Potassium chloride injection, Hospira
20 mEq/L, 5% dextrose 12 count (NDC 00409-7905-09)
 
Potassium Chloride in Dextrose and Lactated Ringers
Potassium chloride injection, Baxter
20 mEq/L, 5% dextrose and lactated ringers 14 count (NDC 00338-0811-04)
 
Potassium chloride injection, Hospira
20 mEq/L, 5% dextrose and lactated ringers 12 count (NDC 00409-7111-09)
 
Potassium Chloride in Dextrose and Sodium Chloride
Potassium chloride injection, Baxter
10 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0669-04)
20 mEq/L, 5% dextrose and 0.2% sodium chloride 14 count (NDC 00338-0663-04)
20 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0671-04)
20 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count (NDC 00338-0803-04)
30 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0673-04)
40 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0675-04)
40 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count (NDC 00338-0807-04)
20 mEq/500 mL, 5% dextrose and 0.2% sodium chloride 14 count (NDC 00338-0663-03)
20 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count (NDC 00338-0671-03)
 
Potassium chloride injection, Hospira
10 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7993-09)
20 mEq/L, 5% dextrose and 0.225% sodium chloride 12 count (NDC 00409-7901-09)
20 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7902-09)
20 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count (NDC 00409-7107-09)
30 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7903-09)
40 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7904-09)
40 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count (NDC 00409-7109-09)
10 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count (NDC 00409-7902-03)

Potassium Chloride in Sodium Chloride
Potassium chloride injection, Baxter
20 mEq/L, 0.45% sodium chloride 14 count (NDC 00338-0704-34)
20 mEq/L, 0.9% sodium chloride 14 count (NDC 00338-0691-04)
40 mEq/L, 0.9% sodium chloride 14 count (NDC 00338-0695-04)
 
Potassium chloride injection, Hospira
20 mEq/L, 0.45% sodium chloride 12 count (NDC 00409-9257-39)
20 mEq/L, 0.9% sodium chloride 12 count (NDC 00409-7115-09)
40 mEq/L, 0.9% sodium chloride 12 count (NDC 00409-7116-09)

Potassium Chloride in Sterile Water
Potassium chloride injection, Baxter
10 mEq/50 mL, sterile water 24 count (NDC 00338-0705-41)
10 mEq/100 mL, sterile water 24 count (NDC 00338-0709-48)
20 mEq/50 mL, sterile water 24 count (NDC 00338-0703-41)
20 mEq/100 mL, sterile water 24 count (NDC 00338-0705-48)
40 mEq/100 mL, sterile water 24 count (NDC 00338-0703-48)
 
Potassium chloride injection, Hospira
10 mEq/50 mL, sterile water 24 count (NDC 00409-7075-14)
10 mEq/100 mL, sterile water 24 count (NDC 00409-7074-26)
20 mEq/50 mL, sterile water 24 count (NDC 00409-7077-14)
20 mEq/100 mL, sterile water 24 count (NDC 00409-7075-26)
40 mEq/100 mL, sterile water 24 count (NDC 00409-7077-26)

Estimated Resupply Dates

Hospira has potassium chloride 2 mEq/mL 250 mL vials and 10 mEq/500 mL in 5% dextrose and 0.225% sodium chloride on back order and the company cannot estimate a release date.

Related Shortages

Updated

November 29, September 21 and 9, August 10, July 7, June 8, May 4, March 11, January 27 and 4, 2016; December 23, 21 and 3, November 11, October 5, August 25, 20 and 12, July 16 and 2, May 21 and 11, April 8, March 23 and 9, February 19 and 2, January 14, 2015; December 10 and 2, November 12, October 23, September 24 and 5, August 6, July 17 and 2, May 29 and 22, April 15 and 1, March 14, February 27, January 22, 2014; December 16 and 5, November 8, October 9, September 26, August 29 and 6, July 30 and 3, June 25 and 4, May 28, April 29 and 1, March 8, February 7, 2013; December 13, November 7, October 26 and 1, September 12, August 27 and 10, July 26 and 6, June 13 and 1, May 30, 15 and 2, April 18, March 21 and 12, February 28, 2012, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing